Stem Cell Authority, Ltd. (SCAL)

Stem Cell Authority Income Statement

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Aug 31, 2009	Aug 31, 2008	Aug 31, 2007	Dec 31, 2006	Dec 31, 2005
Operating Revenue	3.33	0.01	1.13	-	-
Other Revenue	0	0.02	-	-	-
Revenue	3.33	0.03	1.13	-	-
Revenue Growth (YoY)	11044.25%	-97.35%	-	-	-
Cost of Revenue	1.06	0.05	0.35	-	-
Gross Profit	2.27	-0.02	0.77	-	-
Selling, General & Admin	0.43	1.35	0.44	0.63	0.05
Research & Development	-	-	0.06	-	-
Other Operating Expenses	0	0.01	-	-	-
Operating Expenses	0.44	1.37	0.51	0.63	0.05
Operating Income	1.83	-1.39	0.26	-0.63	-0.05
Interest Expense	-	-	-0.07	-0.03	-
Other Non Operating Income (Expenses)	-	-	-	-	-0
Pretax Income	1.83	-1.39	0.19	-0.66	-0.05
Income Tax Expense	-	-	-0.77	-	-
Net Income	1.83	-1.39	0.95	-0.66	-0.05
Net Income to Common	1.83	-1.39	0.95	-0.66	-0.05
Shares Outstanding (Basic)	349	349	170	81	85
Shares Outstanding (Diluted)	349	349	170	81	85
Shares Change (YoY)	-	105.06%	109.32%	-4.56%	-29.71%
EPS (Basic)	0.01	-0.00	-	-0.01	-0.00
EPS (Diluted)	0.01	-0.00	-	-0.01	-0.00
Free Cash Flow	-	-	0.01	-0.7	-0.05
Free Cash Flow Per Share	-	-	-	-0.01	-0.00
Gross Margin	68.18%	-68.24%	68.76%	-	-
Operating Margin	55.06%	-4643.98%	23.45%	-	-
Profit Margin	55.06%	-4643.98%	84.82%	-	-
Free Cash Flow Margin	-	-	1.28%	-	-
EBITDA	-	-1.37	0.28	-	-
EBITDA Margin	-	-	24.61%	-	-
D&A For EBITDA	-	0.01	0.01	-	-
EBIT	1.83	-1.39	0.26	-0.63	-0.05
EBIT Margin	55.06%	-	23.45%	-	-
Revenue as Reported	3.33	0.03	-	-	-
Advertising Expenses	0.07	0.12	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.